FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


7425 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 615170453
Medicinal product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1364130978
Medicinal product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
theophylline 200 mg modified release tablet
theophylline 250 mg modified release tablet
theophylline 300 mg modified release tablet
thiamine hydrochloride 100 mg/mL injection, ampoule
thiamine hydrochloride 100 mg/mL injection, vial
thiamine hydrochloride 100 mg tablet
thiopental sodium 470 mg injection, vial
thiopental sodium 500 mg injection, vial
thioridazine hydrochloride 10 mg tablet
thioridazine hydrochloride 100 mg tablet
thioridazine hydrochloride 25 mg tablet
thioridazine hydrochloride 50 mg tablet
thiotepa 100 mg injection, vial
thiotepa 15 mg injection, vial
thiotepa 400 mg injection, chamber
thyrotropin alfa 900 microgram injection, vial
tiagabine 10 mg tablet
tiagabine 15 mg tablet
tiagabine 2.5 mg tablet
tiagabine 5 mg tablet
tiaprofenic acid 300 mg tablet
tibolone 2.5 mg tablet
ticagrelor 90 mg dispersible tablet
ticagrelor 90 mg tablet
tick antivenom 200 units injection, vial
ticlopidine hydrochloride 250 mg tablet
tigecycline 50 mg injection, vial
tiger snake antivenom 3000 units injection, vial
tilactase 51 mg chewable tablet
tilactase 9 thousand ALU chewable tablet
tildrakizumab 100 mg/mL injection, syringe
tiludronate 200 mg tablet
timolol 0.1% eye gel
timolol 0.25% eye drops
travoprost 0.004% + timolol 0.5% eye drops
timolol 0.5% eye drops
tinidazole 500 mg tablet
tioguanine 40 mg tablet
tiotropium 13 microgram powder for inhalation, capsule
tiotropium 18 microgram powder for inhalation, 1 capsule
tiotropium 2.5 microgram/actuation inhalation solution, actuation
trifluridine 15 mg + tipiracil 6.14 mg tablet
trifluridine 20 mg + tipiracil 8.19 mg tablet
tipranavir 100 mg/mL oral liquid
tipranavir 250 mg capsule
tirofiban 12.5 mg/250 mL injection, bag
tirofiban 12.5 mg / 50 mL injection, 50 mL vial (medicinal product unit of use)
tirofiban 25 mg/500 mL injection, bag
tirzepatide 10 mg/0.5 mL injection, pen device
tirzepatide 12.5 mg/0.5 mL injection, pen device
tirzepatide 15 mg/0.5 mL injection, pen device
tirzepatide 2.5 mg/0.5 mL injection, pen device
tirzepatide 5 mg/0.5 mL injection, pen device
tirzepatide 7.5 mg/0.5 mL injection, pen device
titanium dioxide 8.5% cream
titanium dioxide 9.8% + zinc oxide 2% cream
titanium dioxide 9.8% + zinc oxide 2% lotion
tixagevimab 150 mg/1.5 mL injection, vial
tobramycin 20 mg/2 mL injection, vial
tobramycin 28 mg powder for inhalation, 1 capsule
tobramycin 0.3% eye ointment
tobramycin 0.3% eye drops
tobramycin 300 mg/5 mL inhalation solution, ampoule
tobramycin 500 mg/5 mL injection, vial
tobramycin 80 mg/2 mL injection, ampoule
tobramycin 80 mg/2 mL injection, vial
tocilizumab 162 mg/0.9 mL injection, pen device
tocilizumab 162 mg/0.9 mL injection, syringe
tocilizumab 200 mg/10 mL injection, vial
tocilizumab 400 mg/20 mL injection, vial
tocilizumab 80 mg/4 mL injection, vial
tofacitinib 10 mg tablet
tofacitinib 11 mg modified release tablet
tofacitinib 5 mg tablet
tolnaftate 1% cream
tolnaftate 1% ointment
tolnaftate 1% powder
tolnaftate 1% lotion
tolnaftate 0.07% spray
tolnaftate 0.09% (900 microgram/g) spray
tolnaftate 0.09% (920 microgram/g) spray
tolterodine tartrate 1 mg tablet
tolterodine tartrate 2 mg tablet
tolvaptan 15 mg tablet
tolvaptan 30 mg tablet
tolvaptan 45 mg tablet
tolvaptan 60 mg tablet
tolvaptan 90 mg tablet
topiramate 100 mg tablet
topiramate 15 mg capsule
topiramate 200 mg tablet
topiramate 25 mg capsule
topiramate 25 mg tablet
topiramate 50 mg capsule
topiramate 50 mg tablet
topotecan 1 mg injection, vial
topotecan 4 mg/4 mL injection, vial
topotecan 4 mg injection, vial
toremifene 60 mg tablet
tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial
tozinameran injection, 0.4 mL vial

Start Previous Page 71 of 75 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start